US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street JournalI
IGC
IGC Pharma Inc
0.29
-0.01-2.00%After Hours: 0.2988 +0.0048 +1.63%19:57 03/28 EDT
OPEN/PREV CLOSE0.2965/0.3000
TODAY RANGE0.2870-0.2987
VOL268.11K
MARKET CAP23.43M
52 WEEK RANGE0.2608-0.9099
AVG VOL (3M)396.00K
% TURNOVER0.34%
TURNOVER--
P/E (TTM)-2.3748
% RANGE3.73%
EPS(TTM)-0.1238
P/E(FORWARD)-2.9400
P/B3.675
BVPS0.0800
DIVIDEND--
P/S14.55
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP21.67M
SHARES OUTSTANDING79.69M
NEXT EARNINGS06/23-06/27
FREE FLOAT73.70M
LOT SIZE1
EX-DIV DATE04/19/2013
News
Press Releases
Financial Reports
Profile
Dow Jones·03/06 18:12
IGC Pharma Price Target Maintained With a $3.50/Share by Alliance Global Partners
TipRanks·03/04 14:16
IGC Pharma develops AI-driven model to improve diagnosis of Alzheimer’s
Dow Jones·02/24 13:02
IGC Pharma Is Maintained at Buy by Ascendiant Capital
Dow Jones·02/24 13:02
IGC Pharma Price Target Raised to $4.25/Share From $4.00 by Ascendiant Capital
Benzinga·02/24 12:52
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $4.25
TipRanks·02/20 14:25
IGC Pharma expands Holiby line with ‘Longevity’, ‘Renew’
Seeking Alpha·02/18 17:33
IGC Pharma GAAP EPS of -$0.02, revenue of $257M
TipRanks·02/18 14:25
IGC Pharma reports Q3 EPS (2c) vs. (9c) last year
Same Industry
Name/Symbol
Change%
Price